Acute Myelogenous Leukemia
Showing NaN - NaN of 60
Acute Myelogenous Leukemia Trial in France, United States (Inecalcitol, Placebo Oral Tablet)
Unknown status
- Acute Myelogenous Leukemia
- Inecalcitol
- Placebo Oral Tablet
-
San Diego, California
- +7 more
Jun 30, 2017
Refractory Leukemia, Acute Myelogenous Leukemia Trial in Worldwide (Panobinostat/LBH589)
Completed
- Refractory Leukemia
- Acute Myelogenous Leukemia
-
Chicago, Illinois
- +39 more
Jan 8, 2017
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)
Terminated
- Acute Myelogenous Leukemia
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 16, 2016
Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston
Terminated
- Myelodysplastic and Myeloproliferative Disorders
- +7 more
- Campath
- +4 more
-
Houston, Texas
- +1 more
Mar 29, 2016
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (IGN523)
Completed
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
-
La Jolla, California
- +5 more
Feb 22, 2016
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
-
Los Angeles, California
- +7 more
Jun 4, 2015
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Houston (TH-302)
Completed
- Acute Myelogenous Leukemia
- +5 more
-
Houston, TexasUniversity of Texas M.D. Anderson Cancer Center
May 5, 2015
Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564
Completed
- Acute Myelogenous Leukemia
- +3 more
- BMS-936564 (Anti-CXCR4)
-
Birmingham, Alabama
- +10 more
Mar 5, 2015
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)
Completed
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
-
Phoenix, Arizona
- +19 more
Mar 17, 2014
Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)
Completed
- Acute Myelogenous Leukemia
- clofarabine (IV formulation)
- +2 more
-
Scottsdale, Arizona
- +56 more
Mar 17, 2014
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- clofarabine
- +2 more
-
Birmingham, Alabama
- +12 more
Mar 17, 2014
Acute Myelogenous Leukemia Trial in United States (clofarabine (IV formulation))
Completed
- Acute Myelogenous Leukemia
- clofarabine (IV formulation)
-
Los Angeles, California
- +11 more
Mar 17, 2014
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine, Gemtuzumab ozogamicin)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Decitabine
- Gemtuzumab ozogamicin
-
Houston, TexasUT MD Anderson Cancer Center
Sep 3, 2013
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Revlimid)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Houston, TexasUT MD Anderson Cancer Center
Aug 5, 2013
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine, Gemtuzumab Ozogamicin)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Decitabine
- Gemtuzumab Ozogamicin
-
Houston, TexasUT MD Anderson Cancer Center
Feb 4, 2013
Acute Myelogenous Leukemia Trial in Houston (Decitabine)
Completed
- Acute Myelogenous Leukemia
-
Houston, TexasUT MD Anderson Cancer Center
Jan 25, 2013
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia Trial in Houston, Seattle (PR104)
Unknown status
- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
-
Houston, Texas
- +1 more
Aug 30, 2012
Acute Myelogenous Leukemia, Chemo-induced Nausea and Vomiting Trial in Houston (Ondansetron, Palonosetron)
Completed
- Acute Myelogenous Leukemia
- Chemotherapy-induced Nausea and Vomiting
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (5-Azacytidine, Ara-C, Valproic Acid (VPA))
Completed
- Acute Myelogenous Leukemia
- +2 more
- 5-Azacytidine
- +2 more
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (Voriconazole, Liposomal amphotericin B)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Voriconazole
- Liposomal amphotericin B
-
Houston, TexasThe University of Texas M D Anderson Cancer Center
Aug 1, 2012
Effectiveness of Protected Environment Rooms for AML and MDS
Terminated
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
Houston, TexasUT MD Anderson Cancer Center
Aug 1, 2012
Quality of Life of Acute Myelogenous Leukemia or Myelodysplastic
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Questionnaire
- Neurocognitive Testing
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 31, 2012
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Leukemia Trial in Houston (Azacitidine, Ara-C)
Completed
- Acute Myelogenous Leukemia
- +2 more
-
Houston, TexasU.T.M.D. Anderson Cancer Center
Jul 26, 2012
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia Trial in Houston (Mylotarg, Fludarabine,
Completed
- Acute Myelogenous Leukemia
- +2 more
- Mylotarg
- +4 more
-
Houston, TexasMD Anderson Cancer Center
Jul 31, 2012